Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung

BACKGROUND: A primary pulmonary invasive mucinous adenocarcinoma (IMA) is a rare subtype of invasive adenocarcinoma of the lung. The prognosis of advanced IMA depending on chemotherapy regimen has not been fully investigated. Here, we compared the clinical outcomes of patients with advanced IMA trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoon Jung, Hyun, Dong-gon, Choi, Chang-Min, Lee, Dae Ho, Kim, Sang-We, Yoon, Shinkyo, Kim, Woo Sung, Ji, Wonjun, Lee, Jae Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235206/
https://www.ncbi.nlm.nih.gov/pubmed/34174841
http://dx.doi.org/10.1186/s12885-021-08472-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235206/
https://www.ncbi.nlm.nih.gov/pubmed/34174841
http://dx.doi.org/10.1186/s12885-021-08472-6

Ejemplares similares